Proven Relief. Trusted Results. Backed by Data.

Minitouch is backed by clinical trial results, real-world data, and long-term patient outcomes—all of which demonstrate its effectiveness, safety, and consistency across diverse patient populations. Whether you’re a physician seeking evidence or a patient looking for reassurance, this section delivers the facts.

See Trial Design

From significantly reduced bleeding and pain,

to faster recovery and long-lasting satisfaction, Minitouch offers outcomes that are comparable to hysterectomy—without surgery.

Explore Results

Review Outcomes by Group

Understand the Safety Profile

View Clinical Publications

Read Patient Stories

What You’ll Learn in This Section

0 %

of patients reported significantly reduced bleeding

0 %

reported reduced or eliminated period pain

0 %

experienced no limitations in daily activities within 24 hours

Rate

Extremely low reintervention rate at 3 years

Consistency Across Patient Types

Minitouch delivers consistent success regardless of uterine size, prior C-section, BMI, or age

Designed to treat a broader population than traditional second-gen ablation systems

Exceptional Safety Profile

Zero major adverse events reported in FDA clinical trials

Low risk of complications due to low-temperature, non-sealing technology

Clinical Rigor and Transparency

Published in peer-reviewed abstracts and presented at major gynecology conferences

Built on a foundation of science and outcomes—not marketing claims

Looking for a solution with real-world results and peer-reviewed validation?

Minitouch is the future of endometrial ablation—without compromise.

Explore